← FDA Drug Approvals (Drugs@FDA)

CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LIMITED · Approved 2026-08-11

Drug application

FDA Application #

ANDA213900

Application type

Abbreviated New Drug Application (Generic)

Brand name

CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Generic name

Canagliflozin, Metformin Hydrochloride

Active ingredients

CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Dosage form

TABLET, EXTENDED RELEASE

Route

—

Marketing status

None (Tentative Approval)

Sponsor

AUROBINDO PHARMA LIMITED

First approval

2026-08-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown